MicroPort EP is a Shanghai-based startup aiming to become the leading provider of comprehensive EP solutions. It was founded in 2010 with a primary focus on the development, manufacture, and marketing of minimally invasive medical devices for the treatment of electrophysiological diseases, including cardiac ablation catheters, diagnostic catheters, 3D navigation systems, and more. The company operates within the biotechnology, healthcare, and information technology industries. In its recent funding round in August 2020, MicroPort EP secured a CNY300.00M venture round investment from prominent investors including E-Fund, Grand Flight Investment, Shanghai Pudong Science and Technology Investment, and CITIC Limited. With its innovative products and strategic focus, MicroPort EP presents potential opportunities for venture capitalists looking to invest in the burgeoning medical technology sector.
No recent news or press coverage available for MicroPort EP.